In Reply

The authors respond to the observations and remarks of Cavanna et al. concerning the clinical guidance paper on giant cell tumor of bone (GCTB) in the era of denosumab and update the paper with respect to the European Medicines Agency’s recent positive opinion recommending denosumab for the treatmen...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: van der Heijden, Lizz, Dijkstra, P.D. Sander, van de Sande, Michiel A.J., Kroep, Judith R., Nout, Remi A., van Rijswijk, Carla S.P., Bovée, Judith V.M.G., Hogendoorn, Pancras C.W., Gelderblom, Hans
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AlphaMed Press 2014
Konular:
Letters to the Editor
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221381/
https://ncbi.nlm.nih.gov/pubmed/25378542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0332
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller